Buy Biocon, target price Rs 390: Geojit

According to the brokerage, new product launches and smooth operation amidst US FDA approval for most of the facilities should support longer-term earning growth prospects.

 
– Stocks-Markets-Economic Times

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email